Strong vaccine-induced CD8 T-cell responses have cytolytic function in a chimpanzee clearing HCV infection

PLoS One. 2014 Apr 16;9(4):e95103. doi: 10.1371/journal.pone.0095103. eCollection 2014.

Abstract

A single correlate of effective vaccine protection against chronic HCV infection has yet to be defined. In this study, we analyzed T-cell responses in four chimpanzees, immunized with core-E1-E2-NS3 and subsequently infected with HCV1b. Viral clearance was observed in one animal, while the other three became chronically infected. In the animal that cleared infection, NS3-specific CD8 T-cell responses were observed to be more potent in terms of frequency and polyfunctionality of cytokine producing cells. Unique to this animal was the presence of killing-competent CD8 T-cells, specific for NS3 1258-1272, being presented by the chimpanzee MHC class I molecule Patr-A*03∶01, and a high affinity recognition of this epitope. In the animals that became chronically infected, T-cells were able to produce cytokines against the same peptide but no cytolysis could be detected. In conclusion, in the animal that was able to clear HCV infection not only cytokine production was observed but also cytolytic potential against specific MHC class I/peptide-combinations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • CD8-Positive T-Lymphocytes / drug effects*
  • CD8-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / virology
  • Cytokines / biosynthesis
  • Cytotoxicity, Immunologic / drug effects*
  • Epitopes / chemistry
  • Epitopes / immunology
  • Gene Expression
  • Hepacivirus / immunology*
  • Hepatitis C / immunology
  • Hepatitis C / prevention & control*
  • Hepatitis C / virology
  • Histocompatibility Antigens Class I / genetics
  • Histocompatibility Antigens Class I / immunology
  • Immunity, Cellular / drug effects
  • Immunity, Humoral / drug effects
  • Immunization
  • Molecular Sequence Data
  • Pan troglodytes
  • Viral Core Proteins / administration & dosage
  • Viral Core Proteins / genetics
  • Viral Core Proteins / immunology
  • Viral Hepatitis Vaccines / administration & dosage
  • Viral Hepatitis Vaccines / genetics
  • Viral Hepatitis Vaccines / immunology*
  • Viral Nonstructural Proteins / administration & dosage
  • Viral Nonstructural Proteins / genetics
  • Viral Nonstructural Proteins / immunology

Substances

  • Cytokines
  • Epitopes
  • Histocompatibility Antigens Class I
  • NS3 protein, hepatitis C virus
  • Viral Core Proteins
  • Viral Hepatitis Vaccines
  • Viral Nonstructural Proteins

Grants and funding

This research was initiated by EC grant number QLK2-CT-1999-00356 and supported by ZonMw number 114024014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.